首页> 美国卫生研究院文献>Springer Open Choice >Crossing borders to bind proteins—a new concept in protein recognition based on the conjugation of small organic molecules or short peptides to polypeptides from a designed set
【2h】

Crossing borders to bind proteins—a new concept in protein recognition based on the conjugation of small organic molecules or short peptides to polypeptides from a designed set

机译:跨界结合蛋白质—一种基于小型有机分子或短肽与一组设计多肽结合的蛋白质识别新概念

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A new concept for protein recognition and binding is highlighted. The conjugation of small organic molecules or short peptides to polypeptides from a designed set provides binder molecules that bind proteins with high affinities, and with selectivities that are equal to those of antibodies. The small organic molecules or peptides need to bind the protein targets but only with modest affinities and selectivities, because conjugation to the polypeptides results in molecules with dramatically improved binder performance. The polypeptides are selected from a set of only sixteen sequences designed to bind, in principle, any protein. The small number of polypeptides used to prepare high-affinity binders contrasts sharply with the huge libraries used in binder technologies based on selection or immunization. Also, unlike antibodies and engineered proteins, the polypeptides have unordered three-dimensional structures and adapt to the proteins to which they bind. Binder molecules for the C-reactive protein, human carbonic anhydrase II, acetylcholine esterase, thymidine kinase 1, phosphorylated proteins, the D-dimer, and a number of antibodies are used as examples to demonstrate that affinities are achieved that are higher than those of the small molecules or peptides by as much as four orders of magnitude. Evaluation by pull-down experiments and ELISA-based tests in human serum show selectivities to be equal to those of antibodies. Small organic molecules and peptides are readily available from pools of endogenous ligands, enzyme substrates, inhibitors or products, from screened small molecule libraries, from phage display, and from mRNA display. The technology is an alternative to established binder concepts for applications in drug development, diagnostics, medical imaging, and protein separation.
机译:突出了蛋白质识别和结合的新概念。小分子有机分子或短肽与一组特定设计多肽的缀合提供了结合分子,该结合分子以高亲和力和与抗体相同的选择性结合蛋白质。有机小分子或肽需要结合蛋白质靶标,但仅需具有适度的亲和力和选择性,因为与多肽的缀合会导致分子的结合性能大大提高。所述多肽选自设计成原则上结合任何蛋白质的仅十六个序列的集合。用于制备高亲和力结合剂的少量多肽与用于基于选择或免疫的结合剂技术中使用的庞大文库形成鲜明对比。而且,与抗体和工程蛋白不同,多肽具有无序的三维结构,并能适应与其结合的蛋白质。 C反应蛋白,人碳酸酐酶II,乙酰胆碱酯酶,胸苷激酶1,磷酸化蛋白,D-二聚体和多种抗体的黏合剂分子被用作示例,以证明实现的亲和力高于小分子或肽最多四个数量级。在人血清中通过下拉实验和基于ELISA的测试进行的评估表明,选择性与抗体相同。有机小分子和肽很容易从内源性配体库,酶底物,抑制剂或产物库,筛选的小分子文库,噬菌体展示和mRNA展示中获得。该技术是已建立的粘合剂概念的替代方法,可用于药物开发,诊断,医学成像和蛋白质分离。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号